Evaluation of nk and lak cell activities in neoplastic patients during treatment with morphine

References

• Anderson T. R., Slotkin T. A. Maturation of the adrenal medulla. IV. Effects of morphine. Biochemical Pharmacology 1975; 24: 1469–1473
   Web of Science ®Google Scholar
• Aylesworth C. F., Hodson C. A., Meites J. Opiate antagonists can inhibit mammary tumor growth in rats. Proceeding of the Society for Experimental Biology and Medicine 1979; 161: 18–20
   PubMed Web of Science ®Google Scholar
• Arora P. K., Fride E., Petitto J., Waggie K., Skolnick P. Morphine-induced immune alterations in vivo. Cellular Immunology 1990; 126: 343–353
   PubMed Web of Science ®Google Scholar
• Beleslin D., Polak R. L. Depression by morphine and chloralose of acetylcholine release from the cat's brain. Journal of Physiology, (Lond.) 1965; 177: 411–416
   PubMed Web of Science ®Google Scholar
• Brown S. M., Stimmel B., Taub R. N., Kochwa S., Rosenfield R. E. Immunologic dysfunction in heroin addicts. Archives of Internal Medicine 1974; 134: 1001–1008
   PubMed Web of Science ®Google Scholar
• Cherubin C. E., Baden M., Kavaler F., Lerner S., Cline W. Infective endocarditis in narcotic addiction. Annals of Internal Medicine 1968; 69: 1091–1098
   PubMed Web of Science ®Google Scholar
• Cherubin C. E. The medical sequelae of narcotic addiction. Annals of Internal Medicine 1967; 67: 23–29
   PubMed Web of Science ®Google Scholar
• Clouet D. H., Ratner M. Catecholamine biosynthesis in brains of rats treated with morphine. Science 1970; 168: 854–856
   PubMed Web of Science ®Google Scholar
• Fabris N., Provinciali M. Hormones. Natural Immunity, D. Nelson. Academic Press, Australia 1989; 306–347
   Google Scholar
• Faith R. E., Liang H. J., Murgo A. J., Plotnikoff N. P. Neuroimmunomodulation with enkephalins: enhancement of human natural killer (NK) cell activity in vitro. Clinical Immunology and Immunopathology 1984; 31: 412–418
   PubMedGoogle Scholar
• Gungor M., Genc E., Sagduyu H., Eroglu L., Koyuncuoglu H. Effect of chronic administration of morphine on primary immune response in mice. Experentia 1980; 36: 1309–1312
   PubMedGoogle Scholar
• Hanna N. The role of natural killer cells in the control of tumor growth and metastasis. Biochemica et Biophysica Acta 1985; 780: 213–226
   PubMed Web of Science ®Google Scholar
• Kay N., Allen J., Morley J. E. Endorphine stimulate normal human peripheral blood lymphocyte natural killer activity. Life Science 1984; 35: 53–59
   PubMed Web of Science ®Google Scholar
• Krulich L., Giachetti A., Marchlewska-Koj, Hefco E., Jameson H. E. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat. Endocrinology 1977; 100: 496–501
   PubMed Web of Science ®Google Scholar
• Lewis J. W., Shavit Y., Martin F. C., Terman G. W., Gale R. P., Liebeskind J. C. Effects of stress and morphine on Natural Killer cell activity and on mammary tumor development. Enkephalins and endorphins, N. P. Plotnikoff, R. E. Faith, A. J. Murgo, R. A. Good. Plenum Press, New York 1986; 101–107
   Google Scholar
• Lotti V. J., Kokka N., George R. Pituitary-adrenal activation following intrahypothalamic microinjection of morphine. Neuroendocrinology 1969; 4: 326–330
   PubMed Web of Science ®Google Scholar
• McGinnes K., Chapman G., Marks R., Penny R. A fluorescence NK assay using flow cytometry. Journal of Immunological Methods 1986; 86: 7–15
   PubMed Web of Science ®Google Scholar
• Mandler R. N., Biddison W. E., Mandler R., Serrate S. A. Betaendorphin augments the cytolytic activity and interferon production of natural killer cells. Journal of Immunology 1986; 136: 934–939
   PubMed Web of Science ®Google Scholar
• Mathews P. M., Froelich C. J., Sibbit W. L., Jr, Bankhurst A. D. Enhancement of natural cytotoxicity by Beta-endorphin. Journal of Immunology 1983; 130: 1658–1662
   PubMed Web of Science ®Google Scholar
• McDonough R. J., Madden J. J., Falek A., Shafer D. A., Pline M., Gordon D., Bokos P., Kuehnle J. C., Mendelson J. Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: In vivo evidence for opiate receptor sites on T lymphocytes. Journal of Immunology 1980; 125: 2539–2543
   PubMed Web of Science ®Google Scholar
• Mehrishi J. N., Mills I. H. Opiate receptors on lymphocytes and platelets in man. Clinical Immunology and Immunopathology 1983; 27: 240–249
   PubMedGoogle Scholar
• Monjan A. A., Collector M. I. Stress-induced modulation of the immune response. Science 1977; 196: 307–311
   PubMed Web of Science ®Google Scholar
• Morgan D. R., DuPont H. L., Wood L. V., Kohl S. Cytotoxicity of leucocytes from normal and Shigella-susceptible (opium-treated) Guinea pigs against Shegella sonnei. Infection and Immunity 1984; 46: 22–27
   PubMedGoogle Scholar
• Morley J. E., Kay N., Allen J., Moon T., Billington C. J. Endorphins, immune function and cancer. Psychopharmacology Bulletin 1985; 21: 485–488
   PubMedGoogle Scholar
• Morley J. E., Yamada T., Shulkes A. Effects of morphine addiction and withdrawal on thyrotropin releasing hormone (TRH), somatostatin (SLI) and vasoactive intestinal peptide (VIP). Clinical Research 1979; 27: 75A
   Google Scholar
• Provinciali M., Fabris N. Modulation of lymphoid cell sensitivity to interferon by thyroid hormones. Journal of Endocrinological Investigation 1990a; 13: 187–191
   PubMed Web of Science ®Google Scholar
• Provinciali M., Muzzioli M., Di Stefano G., Fabris N. Recovery of spleen cell Natural Killer activity by thyroid hormone treatment in old mice. Natural Immunity and Cell Growth Regulation, (in press)
   Google Scholar
• Provinciali N., Fabris N. Role of pituitary-thyroid axis on basal and lymphokine-induced NK cell activity in aging. International Journal of Neuroscience 1990b; 51: 273–274
   PubMed Web of Science ®Google Scholar
• Rosemberg S. A. Lymphokine activated killer cells: a new approach to the immunotherapy of cancer. Journal of National Cancer Institute 1985; 75: 595–603
   PubMedGoogle Scholar
• Rosemberg S. A., Mull J. J., Spiess P. J. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin-2. Journal of Experimental Medicine 1985; 161: 1169–1188
   PubMed Web of Science ®Google Scholar
• Shavit Y., Depaulis A., Terman G. W., Martin F. C., Gale R. P., Liebeskind J. C. Evidence for central mediation of morphine's immunosuppressive effects. Federation Proceedings 1985; 44: 1489–1496
   Google Scholar
• Shavit Y., Lewis J. W., Terman G. W., Gale R. P., Liebeskind J. C. Opioid peptides mediate with suppressive effects of stress on natural killer cell cytotoxicity. Science 1984a; 223: 188–192
   PubMed Web of Science ®Google Scholar
• Shavit Y., Terman G. W., Martin F. C., Gale R. P., Liebeskind J. C. Naltrexone-sensitive suppression of the immune system's natural killer cells by morphine. Society of Neuroscience 1984b; 10: 726, Abstract
   Google Scholar
• Small C. B., Klein R. S., Friendland G. H., Moll B., Emerson E. E., Spigland I. Community-acquired opportunistic infectious and defective cellular immunity in heterosexual drug abusers and hemo-sexual men. American Journal of Medicine 1983; 74: 433–436
   PubMed Web of Science ®Google Scholar
• Wybran J., Appelboom T., Famaey J. P., Govaerts A. Suggestive evidence for morphine and methionine-enkephalin receptors-like on normal blood T lymphocytes. Journal of Immunology 1979; 123: 1068–1070
   PubMed Web of Science ®Google Scholar
• Zagon I. S., McLaughlin P. C. Effects of chronic morphine administration on pregnant rats and their offspring. Pharmacology 1977; 15: 302–307
   PubMed Web of Science ®Google Scholar
• Zagon I. S., McLaughlin P. C. Opiate antagonists inhibit the growth of metastatic murine neuroblastoma. Cancer Letters 1983; 21: 89–94
   PubMed Web of Science ®Google Scholar